After moving 0.2% during today's afternoon session, McKesson is now trading at a price of $424.25 per share. On average, analysts give it a target price of $472.86.
McKesson Corporation provides healthcare services in the United States and internationally.
Potential McKesson Investors Should Analyze the Following:
-
McKesson has moved 19.0% over the last year.
-
The company has a price to earnings growth (PEG) ratio of 1.56. A number between 0 and 1 could mean that the market is undervaluing McKesson's estimated growth potential
-
McKesson currently returns an annual dividend yield of 0.5%.
Understanding McKesson's Operating Margins
Date Reported | Total Revenue ($ k) | Operating Expenses ($ k) | Operating Margins (%) | YoY Growth (%) |
---|---|---|---|---|
2022-05-09 | 263,966,000 | -10,537,000 | 1 | 0.0 |
2021-05-12 | 238,228,000 | -8,849,000 | 1 | 0.0 |
2020-05-22 | 231,051,000 | -9,182,000 | 1 | -50.0 |
2019-05-15 | 214,319,000 | -8,437,000 | 2 | 100.0 |
2018-05-24 | 208,357,000 | -8,263,000 | 1 | -50.0 |
2017-05-22 | 198,533,000 | -7,788,000 | 2 |
Over the last 6 years, McKesson's operating margins have averaged only 1.3%, with a high coefficient of variability of 38.7%. The firm's margins are declining at a -11.2% compounded yearly rate.